No specific study on the relationship between VEGF-B expression levels and insulin resistance in NAFLD has been reported, so we cannot confirm that the underlying mechanism that VEGF-B triggers insulin resistance in NAFLD is identical to the mechanism that VEGF-B triggers in other insulin resistance disorders. The gene discussed is VEGFB; the disease is metabolic dysfunction-associated steatotic liver disease.